News
4d
Onlymyhealth on MSNChronic Disease Awareness Day 2025: Expert Shares Early Signs You Should Not IgnoreIf you’ve been brushing off persistent fatigue frequent headaches or unexplained weight changes your body might be telling ...
COPD, or chronic obstructive pulmonary disease, affects more than 30 million Americans, yet many have never heard of it. COPD ...
Many everyday symptoms are inconsequential. You have a poor night’s sleep to thank for your bloodshot eyes, or a new lotion ...
Merck & Co – known as MSD outside of the US and Canada – has announced that it will be expanding its respiratory diseases ...
Researchers have found in two longitudinal cohorts that Incorporating chest CT imaging and respiratory symptoms into the ...
If your allergy symptoms—sneezing, itchy eyes, or nasal congestion—continue to be a problem even after using medication, you ...
Here are three health effects to keep an eye on when Canadian wildfire smoke overtakes the area: According to Northeast ...
Many individuals with chronic obstructive pulmonary disease describe exacerbations in personal, varied terms, revealing a ...
Increasingly, research is pointing to the reality that while vapes do not contain the same dangerous chemicals as cigarettes, ...
Research shows that digital inhalers equipped with remote monitoring capabilities may aid in predicting and identifying ...
Results show most people don’t believe the area is safe to live in and most reported at least one new or worsening health ...
5d
Clinical Trials Arena on MSNFirst subject dosed in Upstream Bio’s Phase II trial of verekitug for COPDUpstream Bio has dosed the first subject in the Phase II trial of verekitug in individuals with chronic obstructive pulmonary disease (COPD).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results